Monopar Therapeutics - FORM 10-K - EX-11 - STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS - March 26, 2018

Attached files

file filename
10-K - MONOPAR THERAPEUTICS INC. - Monopar Therapeuticsmnpr_form10k.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Monopar Therapeuticsexhibit_32-1.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeuticsexhibit_31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeuticsexhibit_31-1.htm
EX-14 - CODE OF BUSINESS CONDUCT AND ETHICS - Monopar Therapeuticsexhibit_14.htm
EX-10.16 - CANCER RESEARCH UK LETTER DATED MARCH 21, 2018 - Monopar Therapeuticsexhibit_10-16.htm
EX-10.15 - TSUCHIMOTO EMPLOYMENT AGREEMENT AMENDMENT ONE - Monopar Therapeuticsexhibit_10-15.htm
EX-10.14 - PRX CONSULTING AGREEMENT 2018 - Monopar Therapeuticsexhibit_10-14.htm
EX-10.13 - ANDERSON EMPLOYMENT AGREEMENT - Monopar Therapeuticsexhibit_10-13.htm
EX-10.12 - PRX CONSULTING AGREEMENT 2017 - Monopar Therapeuticsexhibit_10-12.htm
EX-10.11 - MAZAR EMPLOYMENT AGREEMENT - Monopar Therapeuticsexhibit_10-11.htm
EX-10.10 - MAZAR CONSULTING AGREEMENT - Monopar Therapeuticsexhibit_10-10.htm
EX-10.9 - TSUCHIMOTO EMPLOYMENT AGREEMENT - Monopar Therapeuticsexhibit_10-9.htm
EX-10.8 - TSUCHIMOTO CONSULTING AGREEMENT - Monopar Therapeuticsexhibit_10-8.htm
EX-10.7 - ROBINSON EMPLOYMENT AGREEMENT AMENDED AND RESTATED - Monopar Therapeuticsexhibit_10-7.htm
EX-10.6 - ROBINSON EMPLOYMENT AGREEMENT - Monopar Therapeuticsexhibit_10-6.htm
EX-10.5 - MONOPAR THERAPEUTICS INC. 2016 STOCK INCENTIVE PLAN - Monopar Therapeuticsexhibit_10-5.htm
EX-10.4 - TACTICGEM CONTRIBUTION AGREEMENT - Monopar Therapeuticsexhibit_10-4.htm
EX-10.3 - ONXEO OPTION AND LICENSE AGREEMENT - Monopar Therapeuticsexhibit_10-3.htm
EX-10.2 - XOMA LICENSE AGREEMENT - Monopar Therapeuticsexhibit_10-2.htm
EX-10.1 - CANCER RESEARCH UK CTOA - Monopar Therapeuticsexhibit_10-1.htm
EX-3.2 - AMENDED AND RESTATE BYLAWS - Monopar Therapeuticsexhibit_3-2.htm
EX-3.1 - SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Monopar Therapeuticsexhibit_3-1.htm
 
Exhibit 11
 
Statement Regarding Computation of Per Share Earnings
 
The statement regarding computation of per share earnings is set forth in Note 2 of the Notes to the Financial Statements of the Company for the years ended December 31, 2017 and 2016.
 

Monopar Therapeutics Reports